Researcher Profiles

Return to member profile

Renping Zhou, PhD

Selected Publications

  1. Formation of persistent hyperplastic primary vitreous in ephrin-A5-/- mice. Son AI, Sheleg M, Cooper MA, Sun Y, Kleiman NJ, Zhou R. Invest Ophthalmol Vis Sci. 2014 Mar 19;55(3):1594-606. doi: 10.1167/iovs.13-12706. PMID:24550361
  2. Growth cone collapse assay. Yue X, Son AI, Zhou R. Methods Mol Biol. 2013;1018:221-7. doi: 10.1007/978-1-62703-444-9_21. PMID:23681632
  3. Further analysis of the lens of ephrin-A5-/- mice: development of postnatal defects. Son AI, Cooper MA, Sheleg M, Sun Y, Kleiman NJ, Zhou R. Mol Vis. 2013;19:254-66. Epub 2013 Feb 3. PMID:23401654
  4. Ephrin-A5 deficiency alters sensorimotor and monoaminergic development. Sheleg M, Yochum CL, Wagner GC, Zhou R, Richardson JR. Behav Brain Res. 2013 Jan 1;236(1):139-47. doi: 10.1016/j.bbr.2012.08.032. Epub 2012 Aug 27. PMID: 22954718
  5. Human cataract mutations in EPHA2 SAM domain alter receptor stability and function Park JE, Son AI, Hua R, Wang L, Zhang X, Zhou R. PLoS One. 2012;7(5):e36564. doi: 10.1371/journal.pone.0036564. Epub 2012 May 3. PMID: 22570727
  6. EphA3 functions are regulated by collaborating phosphotyrosine residues. Shi G, Yue G, Zhou R. Cell Res. 2010 Nov;20(11):1263-75. doi: 10.1038/cr.2010.115. Epub 2010 Aug 10. PMID: 20697431
  7. Regulation of process retraction and cell migration by EphA3 is mediated by the adaptor protein Nck1. Hu T, Shi G, Larose L, Rivera GM, Mayer BJ, Zhou R. Biochemistry. 2009 Jul 14;48(27):6369-78. doi: 10.1021/bi900831k. PMID: 19505147
  8. Distribution of EphA5 receptor protein in the developing and adult mouse nervous system. Cooper MA, Crockett DP, Nowakowski RS, Gale NW, Zhou R. J Comp Neurol. 2009 Jun 1;514(4):310-28. doi: 10.1002/cne.22030. PMID:19326470
  9. Ephrin-A5 regulates the formation of the ascending midbrain dopaminergic pathways. Cooper MA, Kobayashi K, Zhou R. Dev Neurobiol. 2009 Jan;69(1):36-46. doi: 10.1002/dneu.20685. PMID:19003794
  10. Loss of ephrin-A5 function disrupts lens fiber cell packing and leads to cataract. Cooper MA, Son AI, Komlos D, Sun Y, Kleiman NJ, Zhou R. Proc Natl Acad Sci U S A. 2008 Oct 28;105(43):16620-5. doi: 10.1073/pnas.0808987105. Epub 2008 Oct 23. PMID:18948590
  11. A subset of signal transduction pathways is required for hippocampal growth cone collapse induced by ephrin-A5. Yue X, Dreyfus C, Kong TA, Zhou R. Dev Neurobiol. 2008 Sep 1;68(10):1269-86. doi: 10.1002/dneu.20657. PMID:18563700
  12. Expression of the tyrosine kinase receptor EphA5 and its ligand ephrin-A5 during mouse spinal cord development. Washburn CP, Cooper MA, Zhou R. Neurosci Bull. 2007 Sep;23(5):249-55. PMID:17952132
  13. Mitogen-activated protein kinase pathway mediates effects of brain-derived neurotrophic factor on differentiation of basal forebrain oligodendrocytes. Du Y, Lercher LD, Zhou R, Dreyfus CF. J Neurosci Res. 2006 Dec;84(8):1692-702. PMID:17044032
  14. Methylmercury alters Eph and ephrin expression during neuronal differentiation of P19 embryonal carcinoma cells. Wilson DT, Polunas MA, Zhou R, Halladay AK, Lowndes HE, Reuhl KR. Neurotoxicology. 2005 Aug;26(4):661-74. PMID:15990172
  15. Differentiation of the midbrain dopaminergic pathways during mouse development. Hu Z, Cooper M, Crockett DP, Zhou R. J Comp Neurol. 2004 Aug 23;476(3):301-11. PMID:15269972
  16. Neurochemical and behavioral deficits consequent to expression of a dominant negative EphA5 receptor. Halladay AK, Tessarollo L, Zhou R, Wagner GC. Brain Res Mol Brain Res. 2004 Apr 7;123(1-2):104-11. PMID:15046871
  17. Abnormal hippocampal axon bundling in EphB receptor mutant mice. Chen ZY, Sun C, Reuhl K, Bergemann A, Henkemeyer M, Zhou R. J Neurosci. 2004 Mar 10;24(10):2366-74. PMID:15014111
  18. Corpus callosum deficiency in transgenic mice expressing a truncated ephrin-A receptor. Hu Z, Yue X, Shi G, Yue Y, Crockett DP, Blair-Flynn J, Reuhl K, Tessarollo L, Zhou R. J Neurosci. 2003 Nov 26;23(34):10963-70. PMID:14645492
  19. Mistargeting hippocampal axons by expression of a truncated Eph receptor. Yue Y, Chen ZY, Gale NW, Blair-Flynn J, Hu TJ, Yue X, Cooper M, Crockett DP, Yancopoulos GD, Tessarollo L, Zhou R. Proc Natl Acad Sci U S A. 2002 Aug 6;99(16):10777-82. Epub 2002 Jul 17. PMID:12124402
  20. Selective inhibition of spinal cord neurite outgrowth and cell survival by the Eph family ligand ephrin-A5. Yue Y, Su J, Cerretti DP, Fox GM, Jing S, Zhou R. J Neurosci. 1999 Nov 15;19(22):10026-35. PMID:10559410
  21. Ephrin-dependent growth and pruning of hippocampal axons. Gao PP, Yue Y, Cerretti DP, Dreyfus C, Zhou R. Proc Natl Acad Sci U S A. 1999 Mar 30;96(7):4073-7. PMID:10097165
  22. Specification of distinct dopaminergic neural pathways: roles of the Eph family receptor EphB1 and ligand ephrin-B2. Yue Y, Widmer DA, Halladay AK, Cerretti DP, Wagner GC, Dreyer JL, Zhou R. J Neurosci. 1999 Mar 15;19(6):2090-101. PMID:10066262
  23. Expression of GDNF family receptor components during development: implications in the mechanisms of interaction. Yu T, Scully S, Yu Y, Fox GM, Jing S, Zhou R. J Neurosci. 1998 Jun 15;18(12):4684-96. PMID:9614243
  24. Regulation of thalamic neurite outgrowth by the Eph ligand ephrin-A5: implications in the development of thalamocortical projections. Gao PP, Yue Y, Zhang JH, Cerretti DP, Levitt P, Zhou R. Proc Natl Acad Sci U S A. 1998 Apr 28;95(9):5329-34. PMID:9560275
  25. The Eph family receptors and ligands. Zhou R. Pharmacol Ther. 1998 Mar;77(3):151-81. Review. PMID:9576626
  26. Dynamic expression suggests multiple roles of the eph family receptor brain-specific kinase (Bsk) during mouse neurogenesis. Zhang JH, Pimenta AF, Levitt P, Zhou R. Brain Res Mol Brain Res. 1997 Jul;47(1-2):202-14. PMID:9221918
  27. Regulation of topographic projection in the brain: Elf-1 in the hippocamposeptal system. Gao PP, Zhang JH, Yokoyama M, Racey B, Dreyfus CF, Black IB, Zhou R. Proc Natl Acad Sci U S A. 1996 Oct 1;93(20):11161-6. PMID:8855326
  28. Isolation and characterization of Bsk, a growth factor receptor-like tyrosine kinase associated with the limbic system. Zhou R, Copeland TD, Kromer LF, Schulz NT. J Neurosci Res. 1994 Jan;37(1):129-43. PMID:8145300
  29. pp39mos is associated with p34cdc2 kinase in c-mosxe-transformed NIH 3T3 cells. Zhou R, Daar I, Ferris DK, White G, Paules RS, Vande Woude G. Mol Cell Biol. 1992 Aug;12(8):3583-9. PMID:1321340
  30. Ability of the c-mos product to associate with and phosphorylate tubulin. Zhou RP, Oskarsson M, Paules RS, Schulz N, Cleveland D, Vande Woude GF. Science. 1991 Feb 8;251(4994):671-5. PMID:1825142
  31. Host range restrictions of oncogenes: myc genes transform avian but not mammalian cells and mht/raf genes transform mammalian but not avian cells. Li R, Zhou RP, Duesberg P. Proc Natl Acad Sci U S A. 1996 Jul 23;93(15):7522-7. PMID:8755507
  32. Cancer genes by non-homologous recombination. Duesberg PH, Goodrich D, Zhou RP. Basic Life Sci. 1991;57:197-211. Review. No abstract available. PMID:1814284
  33. Avian proto-myc genes promoted by defective or nondefective retroviruses are single-hit transforming genes in primary cells. Zhou RP, Duesberg PH. Proc Natl Acad Sci U S A. 1989 Oct;86(20):7721-5. Erratum in: Proc Natl Acad Sci U S A 1989 Nov;86(22):8747. PMID:2554285
  34. myc protooncogene linked to retroviral promoter, but not to enhancer, transforms embryo cells. Zhou RP, Duesberg PH. Proc Natl Acad Sci U S A. 1988 May;85(9):2924-8. PMID:2834721
  35. Mutagenesis of avian carcinoma virus MH2: only one of two potential transforming genes (delta gag-myc) transforms fibroblasts. Zhou RP, Kan N, Papas T, Duesberg P. Proc Natl Acad Sci U S A. 1985 Oct;82(19):6389-93. PMID:3876558